Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

This study has been terminated.
Cypress Bioscience, Inc.
Information provided by (Responsible Party):
Forest Laboratories Identifier:
First received: March 31, 2011
Last updated: August 23, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):